NASDAQ:GWPH

GW Pharmaceuticals Earnings Date, Estimates, & History

Notice: This company has been marked as potentially delisted and may not be actively trading.
$218.96
0.00 (0.00 %)
(As of 05/5/2021)
Add
Compare
Today's Range
$218.96
▼
$218.96
50-Day Range
$216.90
▼
$219.28
52-Week Range
$87.07
▼
$219.57
VolumeN/A
Average Volume899,771 shs
Market Capitalization$6.86 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.15
Earnings Per ShareRevenue

GW Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GW Pharmaceuticals Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GW Pharmaceuticals (NASDAQ:GWPH) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212$0.72$1.32$1.02
Q2 20211$1.56$1.56$1.56
Q3 20211$1.80$1.80$1.80
Q4 20211$2.04$2.04$2.04
FY 20215$6.12$6.72$6.42

GW Pharmaceuticals (NASDAQ:GWPH) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
4/30/2021Q1 2021($0.03)($0.60)($0.57)($0.60)$157.15 million$152.47 million
2/16/2021Q4 2020($0.68)($0.93)($0.25)($0.93)$145.46 million$148.22 million
11/3/20209/30/2020($0.63)($0.36)+$0.27($0.36)$97.66 million$137.10 million  
8/6/20206/30/2020($0.04)($0.02)+$0.02($0.28)$94.57 million$121.30 million  
5/11/20203/31/2020($0.88)($0.24)+$0.64($0.24)$84.93 million$120.60 million  
2/25/202012/31/2019($0.52)($0.84)($0.32)($0.84)$80.92 million$109.10 million  
11/5/2019Q3 2019($0.87)($0.48)+$0.39($0.48)$86.84 million$90.97 million
8/6/2019Q2($1.74)($0.78)+$0.96($4.10)$37.28 million$72.04 million
5/6/20193/31/2019($2.48)($1.68)+$0.80($1.68)$12.32 million$39.20 million  
2/26/2019Q4 2018($2.97)($2.35)+$0.62($2.35)$7.10 million$6.65 million
11/27/20189/30/2018($2.48)($2.76)($0.28)($2.76)$2.62 million$2.40 million  
8/7/20186/30/2018($2.40)($1.26)+$1.14($1.26)$2.00 million$3.46 million
5/8/20183/31/2018($2.22)($3.12)($0.90)($3.12)$2.04 million$3.35 million
2/5/2018Q1 2018($2.03)($2.43)($0.40)($2.43)$2.18 million$7.73 million
12/4/2017Q4 2017($1.73)($2.18)($0.45)($2.18)$2.50 million$2.86 million
8/7/20176/30/2017($1.73)($2.07)($0.34)($2.07)$2.10 million$3.14 million  
5/9/20173/31/2017($1.50)($1.70)($0.20)($1.70)$2.07 million$2.04 million  
2/7/2017Q117($1.35)($0.77)+$0.58($0.77)$1.85 million$2.54 million  
12/5/2016Q416($1.48)($0.89)+$0.59($0.89)$2.85 million$2.16 million  
8/9/2016Q3 2016($1.73)($0.73)+$1.00($0.73)$3.36 million$3.10 million
5/5/2016Q2 2016($1.71)($1.10)+$0.61($1.10)$6.86 million$3.81 million
2/10/2016Q116($1.53)($0.10)+$1.43($1.20)$4.61 million$5.40 million  
12/7/2015Q415($1.38)($0.85)+$0.53($0.85)$15.00 million$5.60 million
8/6/2015Q315($1.30)($1.60)($0.30)($1.60)$12.82 million$13.55 million
5/11/2015Q215($1.23)($0.58)+$0.65($0.58)$11.38 million$9.43 million  
2/4/2015Q115($0.91)($0.26)+$0.65($0.26)$12.12 million$12.40 million
12/2/2014Q414($0.46)$0.02+$0.48$0.02$9.15 million$12.03 million
8/6/2014Q314($0.62)($0.66)($0.04)($0.66)$12.88 million$13.00 million
5/7/2014Q114($0.30)$0.49+$0.79$1.47$12.48 million$12.55 million
2/5/2014Q1 2014($0.39)($0.31)+$0.08($0.31)$11.54 million$7.49 million
11/19/2013Q4 2013($0.19)($0.29)($0.10)($0.29)$11.42 million$11.52 million  
8/5/2013Q3 2013($0.03)($0.24)($0.21)($0.24)$10.71 million$11.04 million
6/3/2013Q2 2013($0.26)($0.26)($0.26)$11.76 million
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles











GW Pharmaceuticals (NASDAQ:GWPH) Earnings Frequently Asked Questions

How much revenue does GW Pharmaceuticals generate each year?

GW Pharmaceuticals (NASDAQ:GWPH) has a recorded annual revenue of $311.33 million.

How much profit does GW Pharmaceuticals generate each year?

GW Pharmaceuticals (NASDAQ:GWPH) has a recorded net income of -$9.02 million. GWPH has generated -$0.24 earnings per share over the last four quarters.

What is GW Pharmaceuticals's EPS forecast for next year?

GW Pharmaceuticals's earnings are expected to grow from ($1.64) per share to $0.36 per share in the next year.

This page was last updated on 9/22/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.